← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2007Last known activity
Feb 1, 2011
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Indications
Recent trials (12)
- NCT01319669Lead sponsorPhase 2/Phase 3Feb 1, 2011
- NCT01319669Reponsible party - principal investigatorPhase 2/Phase 3Feb 1, 2011
- NCT01236716Reponsible party - principal investigatorPhase 2Nov 1, 2010
- NCT01236716Lead sponsorPhase 2Nov 1, 2010
- NCT01024413Reponsible party - principal investigatorPhase 3Jul 1, 2009
- NCT01024413Lead sponsorPhase 3Jul 1, 2009
- NCT00891579Lead sponsorPhase 2Feb 1, 2009
- NCT00891579Reponsible party - principal investigatorPhase 2Feb 1, 2009
- NCT00922584Lead sponsorPhase 2Dec 1, 2008
- NCT00922584Reponsible party - principal investigatorPhase 2Dec 1, 2008
- NCT00492843Reponsible party - principal investigatorPhase 4Jul 1, 2007
- NCT00492843Lead sponsorPhase 4Jul 1, 2007
Details
- Last known activity
- Feb 1, 2011
Notes
No evidence existent